BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasi G, Ahmed T, Rasini E, Fenoglio D, Marino F, Filaci G, Cosentino M. Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors. J Neuroimmunol 2019;332:233-41. [PMID: 30954278 DOI: 10.1016/j.jneuroim.2019.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Assis MA, Carranza PG, Ambrosio E. A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV. Viruses 2021;13:722. [PMID: 33919273 DOI: 10.3390/v13050722] [Reference Citation Analysis]
2 Vidal PM, Pacheco R. The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia. Front Pharmacol 2020;11:394. [PMID: 32296337 DOI: 10.3389/fphar.2020.00394] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
3 Li M, Zhou L, Sun X, Yang Y, Zhang C, Wang T, Fu F. Dopamine, a co-regulatory component, bridges the central nervous system and the immune system. Biomed Pharmacother 2022;145:112458. [PMID: 34847478 DOI: 10.1016/j.biopha.2021.112458] [Reference Citation Analysis]
4 Espinosa-Cárdenas R, Arce-Sillas A, Álvarez-Luquin D, Leyva-Hernández J, Montes-Moratilla E, González-Saavedra I, Boll MC, Garcia-Garcia E, Ángeles-Perea S, Fragoso G, Sciutto E, Adalid-Peralta L. Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study. J Neuroimmunol 2020;347:577328. [PMID: 32721557 DOI: 10.1016/j.jneuroim.2020.577328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Melnikov M, Pashenkov M, Boyko A. Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential? Int J Mol Sci 2021;22:5313. [PMID: 34070011 DOI: 10.3390/ijms22105313] [Reference Citation Analysis]
6 Gao X, Yamazaki Y, Pecori A, Tezuka Y, Ono Y, Omata K, Morimoto R, Nakamura Y, Satoh F, Sasano H. Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma. Front Endocrinol (Lausanne) 2020;11:587779. [PMID: 33244312 DOI: 10.3389/fendo.2020.587779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Jiang SH, Hu LP, Wang X, Li J, Zhang ZG. Neurotransmitters: emerging targets in cancer. Oncogene 2020;39:503-15. [PMID: 31527667 DOI: 10.1038/s41388-019-1006-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]